Nanomedicine for the prevention, treatment and imaging of atherosclerosis.
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in developed countries, with an increasing prevalence due to an aging population. The pathology underpinning CVD is atherosclerosis, a chronic inflammatory state involving the arterial wall. Accumulation of low density lipo...
Auteurs principaux: | Psarros, C, Lee, R, Margaritis, M, Antoniades, C |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
2012
|
Documents similaires
-
Nanomedicine for the prevention, treatment and imaging of atherosclerosis
par: Psarros, C, et autres
Publié: (2012) -
Nanomedicine for the prevention, treatment and imaging of atherosclerosis.
par: Psarros, C, et autres
Publié: (2012) -
Nanomedicine for Diagnosis and Treatment of Atherosclerosis
par: Jingyun Cheng, et autres
Publié: (2023-12-01) -
Construction of dual nanomedicines for the imaging and alleviation of atherosclerosis
par: Shuihua Zhang, et autres
Publié: (2020-01-01) -
The role of adiponectin at different stages of atherosclerosis in heart failure: associations with myocardial redox state
par: Antonopoulos, A, et autres
Publié: (2010)